Edwards Lifesciences Corp Quarterly Income Tax Expense (Benefit) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Edwards Lifesciences Corp quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q3 2024.
  • Edwards Lifesciences Corp Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $40.7M, a 22.8% decline year-over-year.
  • Edwards Lifesciences Corp Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $186M, a 3.27% decline year-over-year.
  • Edwards Lifesciences Corp annual Income Tax Expense (Benefit) for 2023 was $199M, a 19.1% decline from 2022.
  • Edwards Lifesciences Corp annual Income Tax Expense (Benefit) for 2022 was $246M, a 23.4% increase from 2021.
  • Edwards Lifesciences Corp annual Income Tax Expense (Benefit) for 2021 was $199M, a 113% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $186M $40.7M -$12M -22.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $198M $20.2M -$700K -3.35% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $199M $58.4M +$300K +0.52% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-29
Q4 2023 $199M $67M +$6.1M +10% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-12
Q3 2023 $193M $52.7M -$11.1M -17.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $204M $20.9M -$37.4M -64.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 $241M $58.1M -$4.4M -7.04% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-29
Q4 2022 $246M $60.9M +$19.9M +48.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-12
Q3 2022 $226M $63.8M +$13M +25.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-27
Q2 2022 $213M $58.3M +$2.3M +4.11% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-28
Q1 2022 $210M $62.5M +$11.4M +22.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 $199M $41M -$5.6M -12% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-12
Q3 2021 $205M $50.8M +$11.7M +29.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 $193M $56M +$102M Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-29
Q1 2021 $90.5M $51.1M -$2.8M -5.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q4 2020 $93.3M $46.6M +$11.3M +32% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-13
Q3 2020 $82M $39.1M +$12.1M +44.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 $69.9M -$46.3M -$75.3M -260% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $145M $53.9M +$25.6M +90.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-28
Q4 2019 $120M $35.3M +$44.1M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-14
Q3 2019 $75.5M $27M +$4.2M +18.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-26
Q2 2019 $71.3M $29M +$60.7M Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-27
Q1 2019 $10.6M $28.3M -$28.6M -50.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-28
Q4 2018 $39.2M -$8.8M -$336M -103% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-12
Q3 2018 $375M $22.8M -$18.9M -45.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-25
Q2 2018 $394M -$31.7M -$51.2M -263% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-26
Q1 2018 $445M $56.9M -$6.5M -10.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-26
Q4 2017 $451M $327M +$285M +680% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-14
Q3 2017 $167M $41.7M -$2.1M -4.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-26
Q2 2017 $169M $19.5M -$22.9M -54% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-27
Q1 2017 $192M $63.4M +$23.1M +57.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-27
Q4 2016 $168M $41.9M +$15.6M +59.3% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-15
Q3 2016 $153M $43.8M +$11.2M +34.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-27
Q2 2016 $142M $42.4M +$12.9M +43.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-28
Q1 2016 $129M $40.3M +$1.2M +3.07% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-28
Q4 2015 $128M $26.3M +$2.6M +11% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-16
Q3 2015 $125M $32.6M +$6.6M +25.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-28
Q2 2015 $118M $29.5M -$237M -88.9% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-29
Q1 2015 $355M $39.1M +$22.1M +130% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-29
Q4 2014 $333M $23.7M -$1.5M -5.95% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-17
Q3 2014 $334M $26M +$3M +13% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-29
Q2 2014 $331M $266M +$239M +879% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-29
Q1 2014 $92.4M $17M -$29.7M -63.6% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-29
Q4 2013 $122M $25.2M -$4.7M -15.7% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-19
Q3 2013 $127M $23M -$1.2M -4.96% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-31
Q2 2013 $128M $27.2M +$5.1M +23.1% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-04
Q1 2013 $123M $46.7M +$26.2M +128% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-02
Q4 2012 $96.7M $29.9M +$24.4M +444% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-20
Q3 2012 $72.3M $24.2M +$18.2M +303% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 $54.1M $22.1M +$7.4M +50.3% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 $46.7M $20.5M -$200K -0.97% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-06
Q4 2011 $46.9M $5.5M +$200K +3.77% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-28
Q3 2011 $46.7M $6M -$12.2M -67% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-07
Q2 2011 $58.9M $14.7M +$5.8M +65.2% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 $53.1M $20.7M +$2.9M +16.3% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q4 2010 $50.2M $5.3M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-28
Q3 2010 $18.2M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 $8.9M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
Q1 2010 $17.8M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.